Abstract

Stroke, traumatic brain injury and neurodegenerativedisorders are one of the leading causesof death and disability in both developing and developed countries. A number of drugs including neurotrophic drugs are available for these disorders. Cerebroprotein hydrolysate is the latest oneoffering new hopes to patients suffering from these disorders. Its superiorityis because of different actions which help in faster and more complete nerve repair and growth than other neurotrophic agents. It acts by multiplemechanisms viz.-regulation and improvement of the neuronal metabolism, modulation of the synaptic plasticity, promoting neuronal differentiation and protection against ischemic and neurotoxin lesion, reducing excitotoxic damage, blocking over activation of calcium dependent proteases, and scavenging free oxygen radicals.Till now no serious adversity has been reported

Authors and Affiliations